Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Lange, Falko ^a   Rateitschak, Katja ^a   Fitzner, Brit ^a   Pöhland, Ralf ^b   Wolkenhauer, Olaf ^a   Jaster, Robert ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; STAT1 PROTEIN; ANTINEOPLASTIC AGENT; RECOMBINANT GAMMA INTERFERON; STAT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; COMPUTER SIMULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; FIBROGENESIS; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREATIC STELLATE CELL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ALGORITHM; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; CELL CULTURE; CELL PROLIFERATION; COCULTURE; DRUG EFFECT; FIBROSIS; MALE; METABOLISM; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

MUS;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COMPUTER SIMULATION; FIBROSIS; INTERFERON-GAMMA, RECOMBINANT; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; STAT1 TRANSCRIPTION FACTOR; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 79751533911     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-13     Document Type: Article

References (33)

1. Wolkenhauer O, Auffray C, Baltrusch S, Blüthgen N, Byrne H, Cascante M, Ciliberto A, Dale T, Drasdo D, Fell D, Ferrell JE, Gallahan D, Gatenby R, Günther U, Harms BD, Herzel H, Junghanss C, Kunz M, van Leeuwen I, Lenormand P, Levi F, Linnebacher M, Lowengrub J, Maini PK, Malik A, Rateitschak K, Sansom O, Schäfer R, Schürrle K, Sers C, Schnell S, Shibata D, Tyson J, Vera J, White M, Zhivotovsky B, Jaster R. Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. Cancer Res 2010, 70:12-13. 10.1158/0008-5472.CAN-09-2676, 2802734, 20028868.
2. Eckel F, Schneider G, Schmid RM. Pancreatic cancer: a review of recent advances. Expert Opin Investig Drugs 2006, 15:1395-1410. 10.1517/13543784.15.11.1395, 17040199.
3. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005, 128:1606-1625. 10.1053/j.gastro.2005.04.001, 15887154.
4. Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, Ramm GA, Buchler M, Friess H, McCarroll JA, Keogh G, Merrett N, Pirola R, Wilson JS. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004, 29:179-187. 10.1097/00006676-200410000-00002, 15367883.
5. Jaster R, Emmrich J. Crucial role of fibrogenesis in pancreatic diseases. Best Pract Res Clin Gastroenterol 2008, 22:17-29. 10.1016/j.bpg.2007.10.004, 18206810.
6. Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A, Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005, 128:907-921. 10.1053/j.gastro.2004.12.036, 15825074.
7. Müerköster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse ML, Sebens T, Klöppel G, Kalthoff H, Fölsch UR, Schäfer H. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 2004, 64:1331-1337.
8. Miyamoto H, Murakami T, Tsuchida K, Sugino H, Miyake H, Tashiro S. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004, 28:38-44. 10.1097/00006676-200401000-00006, 14707728.
9. Baumert JT, Sparmann G, Emmrich J, Liebe S, Jaster R. Inhibitory effects of interferons on pancreatic stellate cell activation. World J Gastroenterol 2006, 12:896-901.
10. Rateitschak K, Karger A, Fitzner B, Lange F, Wolkenhauer O, Jaster R. Mathematical modelling of interferon-γ signalling in pancreatic stellate cells reflects and predicts dynamics of STAT1 pathway activity. Cell Signal 2010, 22:97-105. 10.1016/j.cellsig.2009.09.019, 19781632.
11. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264. 10.1146/annurev.biochem.67.1.227, 9759489.
12. Nukui Y, Picozzi VJ, Traverso LW. Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2000, 179:367-371. 10.1016/S0002-9610(00)00369-X, 10930481.
13. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003, 185:476-480. 10.1016/S0002-9610(03)00051-5, 12727570.
14. Fitzner B, Brock P, Holzhüter SA, Nizze H, Sparmann G, Emmrich J, Liebe S, Jaster R. Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells. Dig Dis Sci 2009, 54:309-320. 10.1007/s10620-008-0366-z, 18612819.
15. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008, 134:248-258. 10.1053/j.gastro.2007.09.034, 2923436, 18166357.
16. Bouros D, Antoniou KM, Tzouvelekis A, Siafakas NM. Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther 2006, 6:1051-1060. 10.1517/14712598.6.10.1051, 16989587.
17. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442. 10.1016/S0092-8674(00)81288-X, 8608597.
18. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84:443-450. 10.1016/S0092-8674(00)81289-1, 8608598.
19. Fitzner B, Brock P, Nechutova H, Glass A, Karopka T, Koczan D, Thiesen HJ, Sparmann G, Emmrich J, Liebe S, Jaster R. Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cell Signal 2007, 19:782-790. 10.1016/j.cellsig.2006.10.002, 17116388.
20. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D, Apte MV. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 2008, 68:2085-2093. 10.1158/0008-5472.CAN-07-2477, 18381413.
21. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008, 68:918-926. 10.1158/0008-5472.CAN-07-5714, 2519173, 18245495.
22. Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP, Schabel FM. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res 1984, 4:717-726.
23. Jaster R, Sparmann G, Emmrich J, Liebe S. Extracellular signal-regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002, 51:579-584. 10.1136/gut.51.4.579, 1773393, 12235084.
24. Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci USA 2004, 101:15172-15177. 10.1073/pnas.0406242101, 523456, 15471990.
25. Levy DE, Darnell JE. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002, 3:651-662. 10.1038/nrm909, 12209125.
26. Beirer S. Mathematical modelling of the Jak/Stat1 signal transduction pathway 2007, Berlin: Logos Verlag Berlin GmbH.
27. Begitt A, Meyer T, van Rossum M, Vinkemeier U. Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. Proc Natl Acad Sci USA 2000, 97:10418-10423. 10.1073/pnas.190318397, 27039, 10973496.
28. Wormald S, Zhang JG, Krebs DL, Mielke LA, Silver J, Alexander WS, Speed TP, Nicola NA, Hilton DJ. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J Biol Chem 2006, 281:11135-11143. 10.1074/jbc.M509595200, 16473883.
29. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997, 387:921-924. 10.1038/43213, 9202126.
30. MacDonald N. Biological delay systems: linear stability theory 2003, Cambridge: Cambridge University Press.
31. Maiwald T, Timmer J. Dynamical Modeling and multi-experiment fitting with PottersWheel. Bioinformatics 2008, 24:2037-2043. 10.1093/bioinformatics/btn350, 2530888, 18614583.
32. Yang J, Stark GR. Roles of unphosphorylated STATs in signalling. Cell Res 2008, 18:443-451. 10.1038/cr.2008.41, 18364677.
33. Schilling M, Maiwald T, Bohl S, Kollmann M, Kreutz C, Timmer J, Klingmüller U. Computational processing and error reduction strategies for standardized quantitative data in biological networks. FEBS J 2005, 272:6400-6411. 10.1111/j.1742-4658.2005.05037.x, 16336276.